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Abstract
Background: Periodontal diseases are among the most frequent diseases affecting
children and adolescents. These include gingivitis, localized or generalized aggres-
sive periodontitis (a.k.a., early onset periodontitis which includes generalized or
localized prepubertal periodontitis and juvenile periodontitis) and periodontal
diseases associated with systemic disorders. The best approach to managing peri-
odontal diseases is prevention, followed by early detection and treatment.
Methods: This paper reviews the current literature concerning the most common
periodontal diseases affecting children: chronic gingivitis (or dental plaque-induced
gingival diseases) and early onset periodontitis (or aggressive periodontitis), in-
cluding prepubertal and juvenile periodontitis. In addition, systemic diseases Key words: periodontal disease; children;
pedodontics; early onset periodontitis;that affect the periodontium and oral lesions commonly found in young children
aggressive periodontitis; localized juvenileare addressed. The prevalence, diagnostic characteristics, microbiology, host- periodontitis
related factors, and therapeutic management of each of these disease entities are
thoroughly discussed. Accepted for publication 15 May 2001
Dental clinicians must be adept at diag-
nosis and management of periodontal
disease in children and adolescents.
Periodontal diseases are not limited to
adults. On the contrary, periodontal
diseases are prevalent among children
and adolescents. For example, gingivitis
affects more than 70% of children older
than seven years of age (Page & Schro-
eder 1982, Stamm 1986). Bimstein
(1991) stressed the importance of pre-
vention, early diagnosis and early treat-
ment of periodontal diseases in children
and adolescents because (1) the preva-
lence of and severity of periodontal dis-
eases are high; (2) incipient periodontal
diseases in children may develop into
advanced periodontal diseases in
adults; (3) there is association between
periodontal and systemic diseases; (4)
patients, families, or populations at risk
may be identified and included in
special prevention or treatment pro-
grams; and (5) prevention and treat-
ment of most periodontal diseases are
relatively simple and very effective, pro-
viding lifetime benefits.
The nomenclature and classification
systems we use to describe periodontal
disease have changed periodically over
the past few decades. This leads to some
confusion when one reviews past litera-
ture about disease prevalence, treat-
ment, etc. The Consensus Report of the
1989 World Workshop in Clinical Peri-
odontics used the following criteria to
distinguish various forms of peri-
odontitis: (1) age of onset; (2) rate of
disease progression; (3) distribution of
affected sites; (4) presence or absence of
systemic medical conditions; (5) pres-
ence or absence of specific microbial or
host factors; and (6) response of the dis-
ease to therapy (American Academy of
Periodontology: AAP 1989). The classi-
fication (AAP 1989) was simplified by
the Consensus Report of the First
European Workshop on Periodonto-
logy (Attström & van der Velden 1994),
and more recently, a new classification
of periodontal diseases and conditions
was presented at the 1999 International
Workshop on Periodontics (Armitage
1999). The 1999 International Work-
shop classification system includes a
greater variety of disease categories that
base the diagnosis on clinical history
and findings, relying less on age of on-
set as a major criterion (Table 1).
This paper primarily follows the
classification of periodontal disease
from the 1989 World Workshop in Clin-
ical Periodontics (AAP 1989) when de-
scribing conditions because most clini-
cians are familiar with it. For each con-
dition, we also include the International
Workshop in Periodontics classification
(Armitage 1999) parenthetically to in-
troduce readers to the new system and
to highlight the changes between the
two.
The aim of this paper is to review the
current literature concerning the most
common periodontal diseases affecting
children: chronic gingivitis and early
onset periodontitis, including prepuber-
tal and juvenile periodontitis. In ad-
dition, systemic diseases that affect the
periodontium and oral lesions com-
monly found in young children will be
addressed.
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Table 1. Classifications of periodontitis
The 1989 World Workshop in Clinical Periodontics
I. Adult periodontitis
II. Early-onset periodontitis
A. Prepubertal periodontitis (generalized, localized)
B. Juvenile periodontitis (generalized, localized)
C. Rapidly progressive periodontitis
III. Periodontitis associated with systemic disease
IV. Necrotizing ulcerative periodontitis
V. Refractory periodontitis
The 1994 First European Workshop on Periodontology
I. Early onset periodontitis
II. Adult periodontitis
III. Necrotizing periodontitis




IV. Periodontitis as a manifestation of systemic diseases
V. Necrotizing periodontal diseases
VI. Abscesses of the periodontium
VII. Periodontitis associated with endodontic lesions
VIII. Developmental or acquired deformities and conditions
(I). Chronic Gingivitis (Dental Plaque-
induced Gingival Diseases)
Chronic gingivitis is the most common
periodontal infection among children,
and adolescents. These may include
plaque-induced chronic gingivitis (the
most prevalent form), steroid hormone
related gingivitis, drug-influenced gin-
gival overgrowth, and others. It is char-
acterized by inflammation of the mar-
ginal gingiva without detectable loss of
bone or connective tissue attachment.
The initial clinical findings in gingivitis
include redness and swelling of mar-
ginal gingiva, and bleeding upon prob-
ing. As the condition persists, tissues
that were initially edematous may be-
come more fibrotic. Gingival margins,
normally knife-edged in contour, may
become rolled, and interdental papillae
may become bulbous and enlarged.
Probing depths may increase if signifi-
cant hypertrophy or hyperplasia of the
gingiva occurs.
Histologically, ulceration of the sul-
cular epithelium and inflammatory cell
infiltration of the underlying connective
tissue characterize gingivitis. At the
microscopic level, T-lymphocytes pre-
dominate in children (Seymour et al.
1981) whereas B-cells predominate in
adults (Page & Schroeder 1976).
Matsson & Goldberg (1985) sug-
gested that there is no clear-cut age at
which the gingival reaction to bacterial
insult in children becomes similar to
that in adults. However, there is gradual
increase in gingival activity from early
childhood to adult age. Previously,
Matsson (1978) performed a 21-day ex-
perimental gingivitis study comparing 6
children, aged 4 to 5 years, with 6 den-
tal students, aged 23 to 29 years. They
found that the children developed gin-
givitis less readily than the adults. After
21 days without plaque removal, the
children had less gingival exudate and
a lower percentage of bleeding sites
than the adults. Also, the children had
a smaller increase in gingival crevicular
leukocytes than the adults in response
to plaque accumulation. The study
hypothesized that children may have a
different vascular response than adults.
Gingivitis does not always progress
to periodontitis, but periodontitis is
preceded by gingivitis. According to
Marshall-Day et al. (1955), gingivitis
without evidence of bone loss was con-
fined to a younger age group, and bone
loss without gingival alterations was
rarely found.
Plaque-induced chronic gingivitis is
commonly found in young children and
can be managed by mechanical removal
of plaque and high levels of oral hy-
giene. The etiologic nature of plaque in
gingivitis was demonstrated by experi-
mental gingivitis studies in humans
(Löe et al. 1965, Theilade et al. 1986).
Therefore, dentists and dental hygien-
ists must educate parents and their
children about the importance of oral
hygiene in the prevention of caries and
periodontal diseases. Electric tooth-
brushes and antibacterial mouthrinses
may be useful adjuncts to standard
toothbrushing and flossing for children
who are physically challenged, such as
children with Downs syndrome, and for
children undergoing orthodontic care
(Trombelli et al. 1995, Grossman &
Proskin 1997, Boyd 1989).
Steroid hormone-related gingivitis is
associated with elevated sex hormone
levels that amplify clinical inflamma-
tory changes of gingivitis (Suzuki
1988). Increased levels of estrogen and
progesterone during pregnancy (Löe
1965), during puberty, or in patients
medicated with oral contraceptives
(Kalkwarf 1978) have been reported to
result in increased gingival vascularity
and inflammation. Removal of local
factors is the key to the management of
steroid hormone-related gingivitis;
however, it is often necessary to surgic-
ally excise unresolved gingival over-
growth.
Drug-influenced gingival enlargement
has been observed in patients taking
cyclosporin, phenytoin and calcium
channel blockers, with higher preva-
lence in children (Mariotti 1999, Seym-
our et al. 2000). Gingival enlargement
was reported in 30% of patients taking
cyclosporin (Seymour & Heasman
1992), 50% of patients taking phenytoin
(Hassell 1981), and 15% of patients tak-
ing calcium channel blockers such as
nifedipine (Lederman et al. 1984), vera-
pamil (Pernu et al. 1989), and amlodipi-
ne (Seymour et al. 1994). Gingival en-
largement starts in the interdental pa-
pilla region and spreads to involve the
marginal gingiva. In severe cases the en-
larged gingiva may cover the incisal and
occlusal surfaces of the teeth (Chapple
1996). Histologically, the overgrowth is
fibroepithelial in nature, with epithelial
acanthosis, increased numbers of
fibroblasts and increased collagen pro-
duction. The severity of gingival en-
largement is closely related to the level
of plaque control, and therefore reduc-
tions in dental plaque can limit the se-
verity of the lesion (Mariotti 1999).
Treatment of drug-influenced gingi-
val enlargement should start with oral
hygiene instructions, and scaling and
polishing of the teeth to remove bac-
terial deposits. This may require several
visits. 2¿ daily chlorhexidine rinses
(Lang et al. 1982) should be prescribed
when normal brushing and flossing do
not achieve the desired level of plaque
control. Gingivectomy or gingivoplasty
may be needed to correct gingival con-
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tours for hygienic and esthetic reasons.
The patient and parent should be told
that gingival enlargement may recur
after surgery, and that immaculate
home plaque control and regular peri-
odontal maintenance are the key to de-
creasing the likelihood or severity of re-
currence. In addition, the patient’s
physician should be consulted to deter-
mine if the patient could be switched to
a medication that does not cause gingi-
val enlargement. The dentist should
never recommend that a patient discon-
tinue or change medications without
medical consultation.
(II). Early Onset Periodontitis (New
Classification: Aggressive
Periodontitis)
Characteristics of early onset peri-
odontitis include onset before age 35
years, rapid disease progression, some-
what different distribution of lesions
than in adult periodontitis, and distinct
etiologic characteristics.
1. Prepubertal periodontitis (PP) (new
classification: aggressive periodontitis)
The prevalence of PP ranges from
0.84% to 26.9%, based on a limited
number of case reports (Jamison 1963,
Sweeney et al. 1987, Bimstein et al.
1988). Variation in the reported preva-
lences of PP may depend on genetic fac-
tors, methodological factors, and the
selection of non-random sample popu-
lations (Watanabe 1990). Prepubertal
periodontitis may be generalized or lo-
Table 2. Diagnostic characteristics of prepubertal periodontitis
Localized prepubertal periodontitis (LPP)
O Onset: around 4 years of age or older
O Affected teeth: either few or many teeth
O Gingival manifestation: minor inflammation, if any
O Microbial plaque: minimal
O Alveolar bone destruction: faster than adult periodontitis but much slower than
generalized form of PP
O Functional defects: either neutrophils or monocytes but not both
O Otitis media and upper respiratory infections in some cases
O Amenable to mechanical and antibiotic therapy
Generalized prepubertal periodontitis (GPP)
O Onset: at the time of tooth eruption
O Affected teeth: all primary teeth; the permanent dentition may or may not be affected
O Gingival manifestation: fiery red gingiva with acute inflammation around all teeth;
gingival proliferation, cleft formation, and recession
O Alveolar bone destruction: rapid
O Functional defects: both neutrophils and monocytes
O Absence of PMNs in the gingival tissue and marked increase in peripheral blood white
cell count
O Otitis media and upper respiratory infections in most cases
O Refractory to mechanical and antibiotic therapy
calized and can affect both primary and
mixed dentition. Onset occurs between
the eruption of the primary dentition
and puberty. PP is characterized by se-
vere gingival inflammation, rapid bone
loss, tooth mobility, and tooth loss. Su-
zuki (1988) reported that PP patients
are usually between ages 5 and 8, they
have low caries rates, and there is no
sex predilection. Page et al. (1983) first
described ‘‘prepubertal periodontitis’’
as a disease entity and further subdi-
vided it into a localized form of PP
(LPP) and a generalized form of PP
(GPP). This was based on the clinical
description of only three and two cases,
respectively. Diagnostic characteristics
for prepubertal periodontitis are listed
in Table 2.
Pathogenic bacteria that have been
associated with PP include Actino-
bacillus actinomycetemcomitans (A.a.),
Prevotella intermedia (P.i.), Capnocyto-
phaga species (Delaney & Kornman
1987, Sweeney et al. 1987), Porphyro-
monas gingivalis (P.g.) (Mishkin et al.
1986), and Eikenella corrodens (E.
corrodens) (Delaney & Kornman 1987).
Delaney & Kornman (1987) found an
increased proportion of black-pig-
mented anaerobic rods, E. corrodens,
Capnocytophaga species, A.a., and Fu-
sobacterium nucleatum (F. nucleatum)
in the cultivable flora in LPP patients
compared to controls. Studies have
tried to determine whether PP ulti-
mately progresses to juvenile peri-
odontitis (JP). According to Watanabe
(1990), if pathogenic bacteria around
the deciduous dentition in PP patients
remain to infect the area or neighboring
area during eruption of the permanent
teeth, subsequent infection of newly
erupted permanent teeth may occur.
The coexistence of A.a. in lesions of
both PP and localized juvenile peri-
odontitis (LJP) (Zambon et al. 1983)
may explain the possibility. However,
the possible mechanism of disease pro-
gression needs to be re-evaluated since
not all PP develops into JP.
Although the primary etiology re-
mains bacterial plaque, other factors
may predispose otherwise healthy pa-
tients to PP. These may include ce-
mentum defects (Page & Baab 1985),
functional defects in leukocyte chemo-
taxis (Page et al. 1983), and/or presence
of bacteriophage (Watanabe 1990). It
has been generally recognized that GPP
and leukocyte adhesion deficiency
(LAD) are related. Waldrop et al.
(1987) demonstrated that the molecular
basis of GPP was leukocyte adhesion
deficiency by using monoclonal anti-
bodies against Mac-1, LFA-1, and
p150,95 surface adhesion molecules. On
the other hand, immunological data
about LPP have shown that a neutro-
phil or monocyte chemotaxis defect,
but not both, exists in LPP patients.
Systemic diseases associated with pre-
pubertal periodontitis (new classifi-
cation: periodontitis as a manifestation
of systemic diseases) may include insu-




histiocytosis X, acrodynia, acquired im-
munodeficiency syndrome (AIDS),
Down syndrome, and leukocyte ad-
hesion deficiency.
Insulin dependent diabetes mellitus
(IDDM, Juvenile DM) is a relative or
absolute decrease in insulin secretion or
availability, caused by a genetic defect
in pancreatic beta cell productivity, de-
fective insulin release mechanisms
(Johnes & Mason 1980) or by destruc-
tion of beta cells (Jackson & Guthrie
1986). Bernick et al. (1975), Gislen et
al. (1980), and Cianciola et al. (1982)
studied the association between juvenile
diabetes and periodontal diseases in
young children. Bernick et al. (1975)
examined 50 diabetic children and 36
healthy control children who were
matched for age and oral hygiene sta-
tus. They found that gingival inflam-
mation was more prevalent in the dia-
betic group. Furthermore, Gislen et al.
(1980) showed that diabetic children
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with poor metabolic control appeared
to have greater gingival index scores
than children without diabetes. Cianci-
ola et al. (1982) investigated prevalence
of periodontal disease in IDDM in 263
IDDM patients and 208 control sub-
jects. For children between 11 and 18
years old, 9.8 % of the IDDM patients
showed signs of periodontitis versus
only 1.7% of the controls. They found
no periodontitis in children 10 years old
or younger in either group. The article
argues that probing alone is not suf-
ficient to assess periodontitis, particu-
larly when applied to the mixed den-
tition. Adjunctive use of radiographs
was recommended for the assessment of
periodontitis in children. IDDM pa-
tients have also been shown to have a
reduced PMN response to chemotactic
stimuli (Miller 1972).
Papillon-Lefèvre syndrome (PLS) is
a genetic condition inherited as an
autosomal recessive trait, characterized
by hyperkeratosis of the palms of the
hands and soles of the feet and early
onset periodontitis (Johnes & Mason
1980). Severe periodontitis can affect
both the primary and permanent den-
titions (Smith & Rosenzweig 1967, Gor-
lin et al. 1964). The prevalence of PMN
chemotactic defects in the PLS patients
remains controversial.
Hypophosphatasia is a genetic dis-
order. Diagnostic findings include low
levels of serum alkaline phosphatase
and excretion of phosphoethanolamine,
the substrate for alkaline phosphatase,
in the urine. The disorder can be classi-
fied into 3 types: (1) infantile, an auto-
somal recessive condition occurring be-
fore 6 months of age (the most severe
form); (2) childhood, an autosomal re-
cessive or autosomal dominant con-
dition occurring after 6 months of age;
and (3) adult hypophosphatasia, an
autosomal dominant condition that is
the least severe form (Watanabe 1990).
The most consistent clinical sign is
premature loss of deciduous teeth (Fal-
lon et al. 1984). The teeth may have
large pulp chambers, and skeletal de-
formities may occur. Baer & Benjamin
(1974) claimed that only deciduous
teeth are generally affected. Baab et al.
(1986) reported normal polymorpho-
nuclear leukocyte (PMN) chemotaxis
and abnormal monocyte chemotaxis in
3 children with hypophosphatasia; how-
ever, age range was not designated in
the study.
Neutropenia is a disorder in which
the number of PMNs in the peripheral
blood is below 1000/mm3 in infants, be-
low 1000/mm3 or 1500/mm3 in children,
and below 1800/mm3 in adults. Neutro-
penias associated with oral manifes-
tations in children include agranulo-
cytosis (malignant neutropenia, rare in
children), cyclic neutropenia, chronic
benign neutropenia of childhood,
chronic idiopathic neutropenia, and
familial benign neutropenia. Prichard et
al. (1984) and Cohen & Morris (1961)
reported that cyclic neutropenia was as-
sociated with severe gingivitis with ul-
ceration and frequent history of recur-
rent infections such as otitis media and
upper respiratory infection.
Chediak-Higashi syndrome is a rare
autosomal recessive disease associated
with impaired function of cytoplasmic
microtubules or microtubule assembly
in PMNs. Diagnostic features include
characteristic, abnormally large gran-
ules in granulocytes. According to
Clawson et al. (1978), PMN chemo-
tactic defects in Chediak-Higashi syn-
drome may be due to mechanical inter-
ference in deformability by the giant
cytoplasmic granules. Moreover, im-
paired microtubule assembling function
(Oliver 1976) and hyperadhesiveness
(Keller et al. 1984) were suggested as
the mechanism for PMN chemotactic
defects.
Leukemias are characterized by pro-
gressive uncontrolled proliferation of
white blood cells and classified into
acute and chronic lymphocytic leukem-
ia, acute and chronic granulocytic leu-
kemia, acute and chronic monocytic
leukemia, and other rare forms such as
plasma cell leukemia. Oral manifes-
tations of leukemias in children are gin-
gival hemorrhage, petechiae, lymph-
adenopathy, gingival hyperplasia or
hypertrophy, and gingival pallor.
Bender (1944) and Deasy et al. (1976)
reported association between peri-
odontal disease and leukemia in
children.
Histiocytosis X represents a disturb-
ance of the reticulo-endothelial system.
It results from the proliferation and dis-
semination of pathological Langerhans
cells and includes three disorders: Let-
terer-Siwe disease (the most severe form
and usually occurs in infants or before
age 3); Hand-Schuller-Christian disease
(usually occurs before age 5, but can oc-
cur in adolescents and even in young
adults); and eosinophilic granuloma
(occurs primarily in older children and
young adults) (Hartman & Colonel
1980). Increased susceptibility to bac-
terial infections in histiocytosis X pa-
tients may result from PMN defects
(Tomooka et al. 1986) or decreased
monocyte function (Kragballe et al.
1981).
Acrodynia is a rare disease character-
ized by a wide variety of clinical signs
including gingival and mucosal hyper-
plasia, alveolar bone loss with early loss
of primary teeth, loss of hair, abnormal
cramps, profuse sweating and sali-
vation, and gastrointestinal upsets.
Etiology of acrodynia is known to be a
mercurial toxicity reaction, either actual
mercury poisoning or, more likely, an
idiosyncracy to mercury (Warkany &
Hubbard 1948).
Acquired immunodeficiency syndrome
(AIDS) develops as a result of infection
with the human immunodeficiency vi-
rus (HIV). Children with AIDS may de-
velop an atypical form of acute necrot-
izing ulcerative gingivitis (ANUG)
(Leggott 1987); however, no reports of
prepubertal pediatric AIDS patients
presenting with alveolar bone loss exist.
Down’s syndrome (Trisomy 21 syn-
drome; Mongolism) is a common and
easily recognizable chromosomal aber-
ration. The dentition exhibits a number
of characteristic anomalies including
malformation of the teeth, enamel hy-
poplasia, and microdontia. Other com-
mon oral manifestations include macro-
glossia, fissured or pebbly tongue, and
a high arched palate. Due to a defective
immune system, rampant and pre-
cocious periodontal disease is prevalent.
Barr-Agholme et al. (1998) compared
20 Down’s syndrome patients, aged 9 to
21 years, with 19 healthy controls and
reported that gingival inflammation,
probing depth, calculus, and marginal
bone loss were significantly greater in
the Down’s syndrome group. No sig-
nificant differences were found between
the two groups, regarding levels of
serum IgA, IgG2, IgG3, IgG4, IgM, or
albumin. However, the proportion of
IgG1 in total IgG was significantly
higher in the Down’s syndrome group
compared to the control group.
Leukocyte adhesion deficiency
(LAD) is a genetic disease inherited as
an autosomal recessive condition in
which the expression of Mac-1, LFA-1,
and p150,95 glycoprotein adhesion
molecules on leukocytes is severely re-
duced. Springer et al. (1984) suggested
that LAD occurs as a result of a defect
in the gene that codes for the common
beta subunit of cell surface integrins
which are required for leukocyte diap-
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Table 3. Diagnostic characteristics of juvenile periodontitis
Localized juvenile periodontitis (LJP)
O Onset: around puberty
O Affected teeth: permanent incisors and/or first molars
O Associated microorganism: Actinobacillus actinomycetemcomitans
O Greater prevalence in blacks
O Neutrophil dysfunction and high IgG2 response
O Familial distribution
Generalized juvenile periodontitis (GJP)
O Onset: during late teen years
O Affected teeth: generalized involvement of permanent teeth
O Associated microorganism: not clear (P. gingivalis may be involved)
O Greater prevalence in blacks
O Neutrophil dysfunction
O Familial distribution
edesis. Because emigration of PMNs
from blood vessels is dependent upon
adhesion of PMNs to endothelial cell
surfaces, patients with LAD have a
poor response to bacterial infections.
Therefore, these children are plagued
with recurrent bacterial infections and
impaired wound healing. Patients with
this rare disease present with extremely
acute inflammation, proliferation of the
gingival tissues, and rapid bone loss.
An association between generalized pre-
pubertal periodontitis and LAD was
demonstrated by Waldrop et al. (1987)
and Page et al. (1987).
Treatment for PP has ranged from
scaling and root planing or curettage,
with or without systemic antibiotics, to
the extraction of involved teeth (Watan-
abe 1990). The generalized form, unfor-
tunately, does not respond as favorably
to treatment as the localized form. The
majority of cases have been treated by
extraction of involved deciduous teeth
and permanent teeth. Since these pa-
tients may have associated LAD and
may be undergoing antibiotic therapy
for recurrent serious infections, it is
necessary to have a consultation with
the treating physician.
2. Juvenile periodontitis (JP) (new
classification: aggressive periodontitis)
Juvenile periodontitis, formerly called
periodontosis, occurs in children and
teenagers who are otherwise healthy
and is characterized by a rapid alveolar
bone loss in one or more teeth of the
permanent dentition (Baer 1971). Ter-
minology for this disease entity has re-
peatedly changed. Gottlieb et al. (1923)
first described this condition ‘‘diffuse
atrophy of the alveolar bone.’’ His find-
ings in this case included widened peri-
odontal ligament (PDL), cementopa-
thia and alveolar bone resorption, but
no pathology in gingival tissues. Later,
the degenerative process was termed
periodontosis (Orban & Weinmann
1942), who described three stages of the
disease: degeneration of PDL fibers;
proliferation of the junctional epithel-
ium; and the development of deep
infrabony pockets. The term ‘‘peri-
odontosis’’ was favored by Baer (1971).
In his article, the disease entity was di-
vided into two categories, a localized
form affecting the first molars and in-
cisors, and more generalized form af-
fecting most of dentition. The term
‘‘juvenile periodontitis’’, introduced by
Butler (1969), accurately describes the
disease as an inflammatory process.
Waerhaug (1977) described that the pri-
mary etiology of the disease is subgingi-
val bacterial plaque. The plaque front is
consistently located within 0.2 mm to
1.5 mm from the border of loss of
attachment. The plaque grows with a
faster speed of 3 to 5 microns a day in
this disease compared to 0.2 to 1.0 mm
a day in ordinary cases. Diagnostic
characteristics of juvenile periodontitis
are illustrated in Table 3.
Estimates of the prevalence of JP
vary from 0.1% to 15% (Sjödin et al.
1993, Hart et al. 1993, Saxén 1980,
Löe & Brown 1991, Neely 1992), with
differences attributed to varying cri-
teria, geographics, and a diverse data
base. Reports show greater prevalence
in African-Americans than in Caucasi-
ans (Burmeister et al. 1984, Löe &
Brown 1991, Melvin et al. 1991). Al-
bandar et al. (1997a) estimated preva-
lence of EOP (JP) in a group of school-
children, aged 13 to 17 years, based on
the data of a national survey conducted
during the 1986–1987 school year. They
showed that approximately 10.0% of
African-American, 5.5% of Hispanic,
and 1.3% of white adolescents had EOP.
Hørmand & Frandsen (1979) explained
that the higher incidence of LJP in fe-
males could result from an earlier oc-
currence of the disease in females. Stab-
holz et al. (1998) reported a high preva-
lence of LJP in an Israel population
consisting of 86 individuals from 30
families, aged 12 to 20 years. Out of 86
subjects, 33 individuals from 15 families
showed LJP (38.4%), but none of the
subjects showed signs of generalized
juvenile periodontitis. Except for two
pairs of families with genetic ties, no
familial connections could be traced be-
tween the different nuclear families
affected by LJP, and there were no dif-
ferences in oral hygiene status between
LJP and non-LJP groups. The study
suggests that environmental factors
may influence the occurrence of LJP.
The microflora associated with JP is
mainly composed of Gram-negative,
capnophilic, and anaerobic rods (Slots
1979, Newman & Socransky 1977).
Actinobacillus actinomycetemcomitans
(A.a.), a Gram-negative, non-motile,
coccobacillus has been well documented
in relation to LJP (Newman & Socran-
sky 1977, Slots et al. 1980, 1982, Korn-
man & Robertson 1985). Asikainen et
al. (1991) examined A.a. isolates from
subgingival sites in 136 subjects in Fin-
land and found that among five sero-
types of A.a., serotype b was predomi-
nant in LJP and adult periodontitis,
whereas serotype c predominated in
healthy individuals. Wilson & Hamilton
(1992) also demonstrated that black
subjects with LJP responded to A.a.
serotype b serospecific antigens by the
production of IgG antibodies of the
IgG2 subclass. Lu et al. (1993, 1994)
confirmed this by demonstrating that
IgG2 was markedly elevated over all
other Ig classes reactive with A.a. sero-
type b. Albandar et al. (1997b) found
that EOP patients had higher preva-
lence and levels of P.g., P.i., F. nucleat-
um., C. rectus, and T. denticola com-
pared to healthy controls. P.g., T.
denticola, and P.i., in descending order
of importance, were significantly associ-
ated with the generalized and/or rapidly
progressing disease.
Reports indicate that JP patients
have defects in neutrophil chemotaxis
or phagocytosis (Cianciola et al. 1977,
Clark et al. 1977, Van Dyke et al. 1987,
Suzuki et al. 1984, Kimura et al.1992,
etc.). Neutrophils in LJP patients have
fewer receptors on their plasma mem-
brane for certain chemotaxis-inducing
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factors, such as FMLP, C5a, and
GP110 (Van Dyke et al. 1981, 1983,
1987). Agarwal et al. (1994) further sug-
gested that cytokines, such as tumor ne-
crosis factor (TNF) and interleukin-1
(IL-1), present in the serum of LJP pa-
tients are responsible for priming and
inducing altered response in neutro-
phils. In the study, it was found that
treatment of neutrophils in healthy sub-
jects with LJP-sera resulted in a de-
creased neutrophil chemotactic re-
sponse and down regulation of FMLP
receptors on the cell surface. On the
other hand, pretreatment of LJP-sera
with anti-TNF and anti-IL-1 antibodies
effectively neutralized the ability of
LJP-sera to modulate chemotaxis and
FMLP receptor levels in healthy sub-
jects. Sigusch et al. (1998) found that
EOP patients showed reduced expres-
sion of monocyte HLA-DR, IFN-g,
and IL-2 mRNA, and reduced prolifer-
ation of peripheral blood monocytes,
which are known to be positively ex-
pressed by activated TH1 cells. This in-
dicates an impaired TH1 cell response
in EOP patients. Ozmeric et al. (1998)
further suggested that the IL-8, a
chemoattractant, produced by LJP pa-
tients may be less active than in healthy
individuals.
The etiology of JP can be broadly di-
vided into two categories, bacterial
plaque and impaired host defense
mechanism; therefore, the treatment
should aim to control pathogenic mi-
croflora and compensate for impaired
immune function. Systemic approaches
such as antibiotic therapy are often in-
dicated in the management of JP. In
fact, several studies (Slots & Rosling
1983, Christersson et al. 1985, Korn-
man & Robertson 1985) showed that
scaling and root planing alone failed to
suppress or eliminate A.a. from the dis-
eased site and failed to improve clinical
conditions. Treatment modalities in the
management of JP include mechanical
therapy, such as scaling and root plan-
ing and periodontal surgery, local deliv-
ery of antimicrobials, and systemic
antibiotics such as tetracycline, doxycy-
cline, metronidazone, combination of
metronidazole and amoxicillin, or com-
bination of metronidazole and Aug-
mentin (amoxicillin π clavulanic acid).
Gunsolley et al. (1994) compared
nonsurgical and surgical periodontal
treatment in 23 young patients with se-
vere generalized periodontitis. They
found that P.g. was virtually eliminated
by scaling and root planing while levels
of A.a. were not significantly reduced by
scaling and root planing alone. How-
ever, after flap surgery, the levels of A.a.
were significantly reduced, suggesting
that surgery and/or antibiotics are
necessary to reduce levels of A.a. in
young patients with severe generalized
periodontitis. This result was in agree-
ment with other studies (Slots & Ro-
sling 1983, Lindhe & Liljenberg 1984,
Kornman & Robertson 1985).
Young individuals generally have ex-
cellent healing potential. Therefore, in
JP patients the combination of systemic
antibiotics and regenerative surgery is
often successful in treating intrabony
defects and early furcation involvement.
Mattout and Roche (1984) found com-
plete fill of furcations and significant
supracrestal repair in an 18-year-old JP
patient after treatment with iliac crest
autografts. Mabry et al. (1985) treated
intrabony defects in 16 LJP patients
with a combination of freeze-dried
bone allograft (FDBA) and tetracy-
cline. The group that received systemic
tetracycline therapy and local treatment
with a mixture of tetracycline powder
and FDBA had significantly better res-
Table 4. Therapeutic management of common pediatric oral lesions
Primary herpetic gingivostomatitis
O Topical anesthetics/coating agents:
– 1 to 1 mixture of diphenhydramine (Benadryl) elixir & Maalox [OTC]
– diphenhydramine (Benadryl)/lidocaine/Maalox mouth rinse
– Acyclovir elixir
O Systemic acyclovir antiviral therapy
Recurrent herpes simplex
O Avoidance of perpetuating factors
O Acyclovir (Zovirax) 5% ointment or elixir
O Systemic acyclovir as active treatment or prophylaxis for immunosuppressed patients
Recurrent aphthous stomatitis
O Topical anesthetics/coating agents: Zilactin-B [OTC], Orabase-B [OTC], or Oraloe [OTC]
O Antimicrobial mouthrinses: 0.12% chlorhexidine gluconate
O Topical steroids: triamcinolone (Kenalog) in orabase 0.1%, betamethasone valerate 0.1%
ointment, dexamethasone (Decadron) elixir 0.5 mg/5ml, or fluocinonide (Lidex) gel 0.05%
Candidiasis
O Topical antifungal agents:
– Nysatin (Mycostatin) oral suspension 100,000 units/ml or popsicles
– Clotrimazole (Mycelex) troches or swabs
O Antimicrobial mouthrinses: 0.12% chlorhexidine gluconate
Angular cheilitis
O Topical antifungal agents: nystatin or clotrimazole ointment
O Topical antifungal/steroid agent: nystatin/triamcinolone acetonide (Mucolog II) ointment
O Topical antifungal/antibacterial/steroid agent: hydrocortisone/iodoquinol (Vytone) cream
1%
Geographic tongue
O Topical anesthetic/analgesic mouth rinse: Ulcer-Ease [OTC]
O Topical antifungal/steroid agent: triamcinolone acetonide 0.1% in nystatin suspension
O Alkaline saline mouth rinse
O Topical anesthetics/coating agents: 1 to 1 mixture of diphenhydramine (Benadryl) elixir &
Maalox [OTC]
olution of intrabony defects than the
groups that received FDBA alone or
debridement alone with/without sys-
temic tetracycline. Contrary to these
findings, DiBattista et al. (1995) found
no statistically significant differences
between flap debridement alone and
various regenerative procedures in 7
LJP patients. All patients in this study
received systemic doxycycline. The re-
generative procedures utilized were
ePTFE membranes, ePTFE plus root
conditioning with doxycycline solution
(pH: 2.5), and ePTFE π root con-
ditioning π composite graft.
Based upon the contradictory results,
it is apparent that the results achieved
with regenerative procedures will vary
depending on case selection, the pro-
cedure utilized and operator experience.
Therefore, regenerative procedures
should be selected based on the appro-
priate selection criteria.
(III). Common Intraoral Lesions
Dental care providers must be familiar
with oral lesions that are commonly
found in pediatric patients. The 6 most
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commonly found pediatric oral lesions
are: primary herpetic gingivostomatitis,
recurrent herpes simplex infection, re-
current aphthous stomatitis, diffuse in-
traoral candidiasis, angular cheilitis,
and geographic tongue. Table 4 sum-
marizes the therapeutic management of
each of these conditions.
Primary herpetic gingivostomatitis (PHG)
The primary etiology of this disease is
herpes simplex virus (HSV) type 1.
Viral transmission may occur via oral-
genital or oral-oral direct mucocutane-
ous contact of infected secretions. The
initial infection of PHG primarily af-
fects children under 10 years of age with
a peak incidence at 2–4 years of age,
and secondarily young adults, aged 15
to 25 years (Main 1989). The incuba-
tion period of HSV infection ranges ap-
proximately 3 to 10 days. Clinical mani-
festations include fever, malaise, irrita-
bility, lymphadenopathy, widespread
inflammation in the marginal and at-
tached gingiva, and small clusters of
vesicles throughout the mouth. The ves-
icles often coalescence and burst, form-
ing large ulcers. It often causes severe
pain and debilitation. Consequently,
mastication and swallowing may be too
painful, resulting in dehydration. This
can be managed by supportive treat-
ment with high oral fluid intake or in-
travenous fluid infusion (Dohvoma
1994). PHG is a contagious disease that
usually regresses spontaneously within
12 to 20 days. Amir et al. (1997) re-
ported that acyclovir oral suspension
treatment (15 mg/kg 5 times a day) for
herpetic gingivostomatitis, started
within 3 days of onset, significantly re-
duced the duration of clinical manifes-
tations and infectivity of affected
children.
Recurrent herpes simplex (RHS)
Following primary infection by herpes
simplex virus, the virus ascends through
sensory or autonomic nerves and per-
sists in neuronal ganglia. It becomes
dominant within the nucleus and is pres-
ent as a latent HSV (Corey & Spear
1986). In about 30 to 40% of population,
secondary manifestations may occur as
a result of precipitating factors such as
sunlight, trauma, fever, immunosup-
pression, or stress. These secondary
manifestations are recurrent herpes la-
bialis, herpes genitalis, ocular herpes,
and herpes encephalitis (Park 1988).
Vesicles often develop at the same site
and are usually present in small clusters
following the distribution of the infected
nerve. In healthy individuals, the disease
is limited to periosteal-bound, keratiniz-
ed mucosa whereas recurrences in the
buccal mucosa and tongue may develop
in immunocomprimised patients. The
lesions are most frequently seen as her-
pes labialis, where lesions occur at the
vermillion border of the lip.
Recurrent aphthous stomatitis (RAS)
RAS is the most common oral mucosal
disease in North America (Murray &
Amedee 2000). Approximately 20% of
population experiences minor apthae,
which is the most common form of
childhood RAS (Field et al. 1992).
These ulcerative lesions are often re-
ferred as ‘‘canker sores’’ by the patient.
RAS lesions range from occasional
small (0.5 to 1.0 cm in diameter), well-
defined round or ovoid shallow ulcers
with a gray-yellowish central area sur-
rounded by an erythematous halo to
larger (1 to 3 cm in diameter) oval or
irregular ulcers. Small lesions heal in 7
to 10 days without scarring whereas
larger lesions persist for weeks and heal
with scarring (Eversole 1989). The
etiology is unknown, yet suggested
etiologies include the L-form of strepto-
coccus and/or an immunopathic pro-
cess involving cell-mediated cytolytic
activity in response to HLA or foreign
antigens. Precipitating factors may in-
clude trauma, stress, menstruation, nu-
tritional deficiencies, food allergies, and
endocrinopathies. In children with
Behcet’s disease and HIV infection,
RAS lesions are frequently found
(Krause et al. 1999, Ramos-Gomez et
al. 1999). Clinical management of RAS
may include mouthrinses such as chlor-
hexidine gluconate, topical cortico-
steroids, topical tetracyclines, immuno-
modulators, and others (Porter et al.
1998).
Candidiasis
Candidiasis is the most prevalent my-
cotic infection in the oral mucosa. It is
caused by an overgrowth of a superficial
fungus, Candida albicans, opportunistic
fungus found in the oral cavity, gastro-
intestinal tract, and vagina. Clinically,
it appears as diffuse, curdy, or velvety
white mucosal plaques that can be wip-
ed off. Infants whose mothers display
vaginal thrush at the time of birth and
adults on long-term antibiotics or ster-
oid therapy are frequently affected. In
addition, individuals with diabetes, hy-
poparathyroidism, immunodeficiency,
or those undergoing chemotherapy are
also often affected. Particularly,
children and adolescents with HIV-in-
fection are predisposed to the develop-
ment of oral candidiasis (Flaitz & Hicks
1999). Like other forms of Candida in-
fection, such as angular cheilitis and
geographic tongue, the lesions can be
managed by both topical and systemic
treatment with antifungal medications,
such as Nystatin ointment.
Angular cheilitis
Angular cheilitis, perleche, is a painful
condition beginning as an inflammation
of the commissure of the lips, followed
by erosion, ulceration, and fissuring. It
is known to be associated with Candida
albicans and Staphylococcus aureus.
The possible predisposing factors may
include immunodeficiency, riboflavin
(vitamin B2) deficiency, trauma, and
loss of vertical dimension. According to
Flaitz & Hicks (1999), oral candidiasis,
including angular cheilitis, is the most
common oral manifestation in HIV-in-
fected children. Treatment may include
removal, if possible, of predisposing
factors and application of antifungal
medications.
Geographic tongue (benign migratory
glossitis)
Geographic tongue is a benign in-
flammatory condition that is character-
ized by desquamation of superficial
keratin and the filiform papillae. It af-
fects approximately 1 to 2% of popula-
tion. Kleinman et al. (1994) reported
0.6% prevalence of geographic tongue
in 39,206 U.S. schoolchildren, aged 5–
17 years. The etiology is unknown, but
correlation with nutritional deficiencies
and/or emotional stress has been sug-
gested. The condition is often restricted
to the dorsum and lateral borders of the
tongue. Sometimes these usually benign
lesions can become symptomatic ex-
hibiting a burning sensation. Palliative
treatment, including avoidance of acidic
and spicy foods and drinks is advisable
for those cases exhibiting symptoms.
Topical and systemic antihistamine may
be used to manage the lesions of geo-
graphic tongue (Sigal & Mock 1992).
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Summary
Periodontal diseases are among the
most frequent diseases affecting
children and adolescents. Dental clini-
cians must be aware of the prevalence,
diagnostic characteristics, micro-
biology, host-related factors, and thera-
peutic management of each of these dis-
ease entities. It is well known that the
primary etiology of periodontal dis-
eases is bacterial plaque. However, pa-
tients affected by early onset peri-
odontitis (or aggressive periodontitis)
often present with impaired immune
function, mainly neutrophil dysfunc-
tion. Therefore, it is important when
managing periodontal diseases in
young individuals, the dentist should
rule out systemic diseases that can af-
fect host defense mechanisms. In ad-
dition, commonly found oral lesions
such as primary herpetic gingivostoma-
titis, recurrent herpes simplex, recurrent
aphthous stomatitis, diffuse intraoral
candidiasis, angular cheilitis, and geo-
graphic tongue should be promptly
identified and treated if necessary. It is
believed that the best approach to man-
age periodontal diseases is prevention,
followed by early detection and treat-
ment. To achieve this, profound knowl-
edge about periodontics and pedodont-
ics as well as intimate periodontal-pe-
dodontics interactions are essential.
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Zusammenfassung
Parodontale Erkrankungen bei Kindern und
Heranwachsenden
Hintergrund: Parodontale Erkrankungen ge-
hören zu den häufigsten Erkrankungen, die
Kinder und Heranwachsende betreffen. Dies
bezieht die Gingivitis, die lokalisierte oder
generalisierte aggressive Parodontitis (früh
einsetzende Parodontitis, die die generalisier-
te oder lokalisierte präpubertale Parodontitis
und die juvenile Parodontitis einbezieht) und
parodontale Erkrankungen verbunden mit
systemischen Störungen ein. Der beste Weg
für die Beschäftigung mit parodontalen Er-
krankungen ist die Prävention, gefolgt von
der frühen Entdeckung und der Behandlung.
Methoden: Diese Arbeit bewertet die gegen-
wärtige Literatur die sich mit den häufigsten
parodontalen Erkrankungen bei Kindern be-
schäftigt: chronische Gingivitis (oder Plaque
induzierte gingivale Erkrankungen) und früh
einsetzende Parodontitis (oder aggressive Pa-
rodontitis), einschließlich präpubertale und
juvenile Parodontitis. Zusätzlich werden sy-
stemische Erkrankungen, die das Parodonti-
um und die orale Schleimhaut betreffen und
bei jungen Kindern gewöhnlich gefunden
werden, behandelt. Die Prävalenz, die dia-
gnostischen Merkmale, die Mikrobiologie,
die Wirtsfaktoren und das therapeutische
Management von jeder dieser Erkrankungen
werden gründlich diskutiert.
Résumé
Maladies parodontales chez l’enfant et l’ado-
lescent
Origine: Les maladies parodontales sont par-
mi les maladies les plus fréquentes affectant
les enfants et les adolescents. Elles compren-
nent la gingivite, la parodontite agressive lo-
calisée ou généralisée (parodontite précoce
qui inclut les formes généralisées ou locali-
sées de parodontite prépubertaire et la paro-
dontite juvénile) et les maladies parodontales
associées aux problèmes systémiques. La
meilleure approche pour traiter les maladies
parodontales est la prévention suivie par une
détection précoce et un traitement.
Méthodes: Ce manuscrit revoit la littérature
actuelle concernant les maladies parodonta-
les les plus communes affectant les enfants:
gingivite chronique (ou maladie gingivale in-
duite par la plaque dentair) et parodontite
précoce (ou parodontite agressive) incluant
les parodontites prépubertaire et juvénile. De
plus, les maladies systémiques qui affectent le
parodonte et les lésions orales communément
trouvées chez les jeunes enfants sont reprises.
La fréquence globale, les caractéristiques du
diagnostic, la microbiologie, les facteurs de
l’hôte et l’approche thérapeutique de chacu-
ne de ces entités de maladie sont discutés en
profondeur.
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